Robert W. Baird Lowers Medpace (NASDAQ:MEDP) Price Target to $313.00
Medpace (NASDAQ:MEDP – Get Free Report) had its price objective dropped by equities research analysts at Robert W. Baird from $340.00 to $313.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Robert W. Baird’s price target suggests a potential upside of […]
Medpace (NASDAQ:MEDP – Get Free Report) had its price objective dropped by equities research analysts at Robert W. Baird from $340.00 to $313.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Robert W. Baird’s price target suggests a potential upside of […]